Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: A prospective study

Annals of Oncology

Volumn 14, Issue 11, 2003, Pages 1648-1653

  Huo, T I ^a   Huang, Y H ^a   Wu, J C ^a   Chiang, J H ^a   Lee, P C ^a   Chang, F Y ^a   Dee, S D ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Arterial embolization; Hepatocellular carcinoma; Liver cirrhosis; Percutaneous acetic acid injection

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; DOXORUBICIN; IODINATED POPPYSEED OIL; LIVER ENZYME;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; FOLLOW UP; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENCE RISK; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VOLUME;

ACETIC ACID; ADMINISTRATION, CUTANEOUS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0345688071     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg460     Document Type: Article

References (33)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
2. Hussain SA, Ferry DR, El-Gazzaz G et al. Hepatocellular carcinoma. Ann Oncol 2001; 12: 161-172.
3. Shirabe K, Kanematsu T, Matsumata T et al. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analysis. Hepatology 1991; 14: 802-805.
4. Nagasue N, Uchida M, Makino Y et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-494.
5. Izumi R, Shimizu K, Li T et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106: 720-727.
6. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311-322.
7. Ryder SD, Rizzi PM, Metivier E et al. Chemoembolizaton with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut 1996; 38: 125-128.
8. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985; 56: 918-928.
9. Takayasu K, Shima Y, Muramatsu Y et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with or without chemotherapeutic agents. Radiology 1987; 163: 345-351.
10. Matsui O, Kadoya M, Yoshikawa J et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188: 79-83.
11. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
12. Livraghi T, Giorgio A, Marin G et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-108.
13. Shiina S, Yasuda H, Muto H et al. Percutaneous ethanol injection in the treatment of liver neoplasms. Am J Roentgenol 1987; 149: 949-952.
14. Shiina S, Tagawa K, Niwa Y et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 160: 1023-1028.
15. Vilana R, Bruix J, Bru C et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992; 16: 353-357.
16. Lencioni R, Bartolozzi C, Caramella D et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: analysis of prognostic factors in 105 western patients. Cancer 1995; 76: 1737-1746.
17. Kotoh K, Sakai H, Sakamoto S et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 1994; 89: 194-198.
18. Huo TI, Huang YH, Wu JC et al. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scand J Gastroenterol 2002; 37: 350-355.
19. Ohnishi K, Yoshioka H, Ito S et al. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27: 67-72.
20. Ohnishi K, Nomura F, Ito S et al. Prognosis of small hepatocellular carcinoma (<3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology 1996; 23: 994-1002.
21. Ohnishi K, Yoshioka H, Ito S et al. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. Hepatology 1996; 24: 1379-1385.
22. Huo TI, Huang YH, Wu JC et al. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective controlled study. Scand J Gastroenterol 2003; 38: 770-778.
23. Livraghi T, Goldberg SN, Lazzaroni S et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661.
24. Simonetti RG, Liberati A, Angiolini C et al. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997; 8: 117-136.
25. Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739.
26. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
27. Tanaka K, Nakamura S, Numata K et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 1992; 185: 457-460.
28. Tanaka K, Nakamura S, Numata K et al. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998; 82: 78-85.
29. Bartolozzi C, Lencioni R, Caramella D et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995; 197: 812-818.
30. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001; 35: 421-430.
31. Huang YS, Chiang JH, Wu JC et al. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 2002; 97: 1223-1227.
32. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
33. Rizzi PM, Kane PA, Ryder SD et al. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 1994; 107: 1425-1429.